Latest News about NVCN
Recent news which mentions NVCN
From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
   
  
  
  January 18, 2023
  From Benzinga
 
   Nasdaq Edges Higher; Neovasc Shares Jump
   
  
  
  January 17, 2023
  From Benzinga
 
   Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  January 17, 2023
  From Benzinga
 
   Why Neovasc Shares Are Trading Higher Today
   
  
  
  January 17, 2023
  From Benzinga
 
   Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
   
  
  
  January 17, 2023
  From Benzinga
 
   Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations
   
  
  
  January 17, 2023
  From Benzinga
 
   Shockwave Medical Seeks To Bolster Its Cardiovascular Disease Portfolio With Neovasc Acquisition
   
  
  
  January 17, 2023
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Friday
   
  
  
  November 25, 2022
  From Benzinga
 
   Earnings Scheduled For August 11, 2022
   
  
  
  August 11, 2022
  From Benzinga
 
   Earnings Scheduled For May 12, 2022
   
  
  
  May 12, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Highs On Monday
   
  
  
  May 02, 2022
  From Benzinga
 
   74 Biggest Movers From Yesterday
   
  
  
  April 29, 2022
  From Benzinga
 
   Earnings Scheduled For March 10, 2022
   
  
  
  March 10, 2022
  From Benzinga
 
   The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
   
  
  
  March 06, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
   
  
  
  November 09, 2021
  From Benzinga
 
   Neovasc Receives FDA Approval for COSIRA-II Clinical Trial
   
  
  
  October 19, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
   
  
  
  October 08, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
   
  
  
  August 10, 2021
  From Benzinga
 
   Earnings Scheduled For August 10, 2021
   
  
  
  August 10, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


